Skip to main content

Frequency Therapeutics Short Interest Ratio and Short Volume

-0.15 (-1.71 %)
(As of 05/18/2021 05:13 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume664,811 shs
Average Volume1.12 million shs
Market Capitalization$295.31 million
P/E RatioN/A
Dividend YieldN/A

Short Interest

Frequency Therapeutics (NASDAQ:FREQ) Short Interest Data

Current Short Volume6,080,000 shares
Previous Short Volume7,960,000 shares
Change Vs. Previous Month-23.62%
Dollar Volume Sold Short$60.98 million
Short Interest Ratio / Days to Cover0.0
Last Record DateApril, 15 2021
Outstanding Shares34,219,000 shares
Percentage of Shares Shorted17.77%
Today's Trading Volume664,811 shares
Average Trading Volume1,120,538 shares
Today's Volume Vs. Average-40.67%

Short Interest Over Time

Frequency Therapeutics (NASDAQ:FREQ) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20216,080,000 shares $60.98 million -23.6%N/A0 $10.03
3/31/20217,960,000 shares $67.74 million +91.4%27.0%6.1 $8.51
3/15/20214,160,000 shares $171.31 million -21.8%14.3%5.1 $41.18
2/26/20215,320,000 shares $263.71 million +35.4%18.2%17.9 $49.57
2/12/20213,930,000 shares $208.53 million -3.9%13.5%13.9 $53.06
1/29/20214,090,000 shares $165.65 million -2.2%14.0%15.3 $40.50
1/15/20214,180,000 shares $153.66 million -9.9%14.4%17.3 $36.76
12/31/20204,640,000 shares $173.03 million +13.5%16.0%21.1 $37.29
12/15/20204,090,000 shares $150.06 million +1.2%14.1%19.7 $36.69
11/30/20204,040,000 shares $116.03 million +1.3%14.0%21.8 $28.72
11/15/20203,990,000 shares $99.95 million +0.8%13.8%22.1 $25.05
10/30/20203,960,000 shares $84.98 million -2.2%13.8%24.8 $21.46
10/15/20204,050,000 shares $84.32 million -3.8%14.1%25.8 $20.82
9/30/20204,210,000 shares $80.87 million +2.4%14.7%26.6 $19.21
9/15/20204,110,000 shares $92.48 million +5.7%14.3%18.7 $22.50
8/31/20203,890,000 shares $75.23 million -0.8%13.6%16.4 $19.34
8/14/20203,920,000 shares $86.51 million -0.3%13.7%15.8 $22.07
7/31/20203,930,000 shares $83.08 million -8.0%13.8%15.3 $21.14
7/15/20204,270,000 shares $92.92 million +0.7%15.2%16.7 $21.76
6/30/20204,240,000 shares $90.27 million +52.5%16.3%16.7 $21.29
6/15/20202,780,000 shares $55.41 million +7.8%10.7%13.8 $19.93
5/29/20202,580,000 shares $47.88 million +4.5%9.9%17.4 $18.56
5/15/20202,470,000 shares $48.09 million +2.9%9.5%18.5 $19.47
4/30/20202,400,000 shares $40.92 million +2.1%9.3%21.1 $17.05
4/15/20202,350,000 shares $35.72 million -1.3%9.1%20.4 $15.20

Frequency Therapeutics (NASDAQ:FREQ) Short Interest FAQ

speech bubbles
speech bubbles

What is Frequency Therapeutics' current short interest?

Short interest is the volume of Frequency Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 6,080,000 shares of FREQ short.

Is Frequency Therapeutics' short interest increasing or decreasing?

Frequency Therapeutics saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 6,080,000 shares, a drop of 23.6% from the previous total of 7,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Frequency Therapeutics' short interest compare to its competitors?

0.00% of Frequency Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Frequency Therapeutics: Phibro Animal Health Co. (6.29%), Aclaris Therapeutics, Inc. (4.06%), Rhythm Pharmaceuticals, Inc. (0.00%), Shattuck Labs, Inc. (3.86%), Travere Therapeutics, Inc. (8.08%), Omeros Co. (0.00%), Humanigen, Inc. (17.60%), Pliant Therapeutics, Inc. (7.54%), Ocular Therapeutix, Inc. (0.00%), and Zogenix, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.85 billion), Aon plc ($5.61 billion), Charter Communications, Inc. ($5.44 billion), Snap Inc. ($3.49 billion), Airbnb, Inc. ($3.35 billion), Peloton Interactive, Inc. ($2.53 billion), ViacomCBS Inc. ($2.48 billion), Expedia Group, Inc. ($2.39 billion), The Kroger Co. ($2.26 billion), and Nuance Communications, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Frequency Therapeutics stock?

Short selling FREQ is an investing strategy that aims to generate trading profit from Frequency Therapeutics as its price is falling. Frequency Therapeutics' stock is trading down $0.15 today. To short Frequency Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Frequency Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Frequency Therapeutics?

A short squeeze for Frequency Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FREQ, which in turn drives the price of the stock up even further.

How often is Frequency Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FREQ, twice per month. The most recent reporting period available is April, 15 2021.

This page was last updated on 5/18/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.